GSK8814 is primarily utilized in the field of medical research, particularly in the study of autoimmune diseases and inflammatory conditions. It functions as a selective inhibitor targeting specific pathways involved in immune system regulation. Researchers employ this compound to investigate its potential in modulating immune responses, which could lead to the development of novel therapies for conditions such as rheumatoid arthritis, lupus, and other autoimmune disorders. Its application in preclinical studies helps in understanding the underlying mechanisms of inflammation and immune dysregulation, paving the way for targeted treatment strategies. Additionally, GSK8814 is used in pharmacological studies to assess its efficacy, safety, and potential side effects, contributing to the advancement of immunology and drug discovery.